Performance Measurement Network

List of All Questions in the FAQ Database

Clinical Specification Questions

Question Related to
Is Xarelto (Rivaroxaban an acceptable anticoagulant for STK-3?) STK-03
Abstraction for Clinical Trial (STK ) STK
Is intensive dosing of statin required to meet STK-6? STK
Assessed for Rehabaliitation Services STK-10
Are patients that stroke while an inpatient included in the measure population? STK
IV Alteplase STK-OP
Follow-up to UserQuestionId03Stk100984 STK-04
Question regarding the new STK OP 1 Measure STK-OP
Rehabilitation Assessment STK
Discharge Instructions for Activation of Emergency Medical System (EMS (911)) STK-08
Activity specifics ACHF
Referral to Next Level of Care Provider-Trasmittal Question HBIPS-6
Can documentation on a pre-printed stroke order form for VTE Prophylaixs be used as a sufficient reason for no prophylaxis? STK-01
PRE-stroke Modified Rankin Indicator question for Cstroke reporting CSTK-02
Reason for extending IV tPA STK-4
STK 10 Assessed for rehabilitation STK-10
Primary Stroke Certification and Transition to Stroke Core Measures STK
What are the benchmarks for the new Outpatient Stroke Core Measures? STK-OP
Is the ambulatory patient considered low risk for VTE? STK
What dose of enoxaparin is acceptable for use as antithrombotic therapy. STK-2, STK-5
Abstraction for Last Known Well STK-04
Last known well when symptoms resolve then reoccur STK
Patient Ambulatory At End of Hospital Day 2 STK
Support System ACHF
Patients transferred after t-PA STK
WIll the new medication Pradaxa be acceptable as an anticoagulant at discharge? STK, STK-03
Comprehensive Stroke (CSTK Sub-Populations) CSTK
Questions about sampling? ACHF
Exclusive breast milk feeding definition PC
If the admitting diagnosis is not stroke, can the case be excluded from STK-4? STK-04
Will files be rejected if all procedure codes do not have a procedure time? CSTK, CSTK-01, CSTK-03
Documention of Stroke education at discharge, STK-08
Procedure codes for HF outpatients ACHF
Birth Weight suggested Sources PC-06
Documentation Compliance for IV t-PA STK, STK-04
Patients with subsequent admissions to the psychiatric unit HBIPS-1, HBIPS-6, HBIPS-7
Positive Brain Image CSTK
What dosage of Lovenox is suffiecient to meet antithrombotic therapy administered by end of hospital day 2 STK-05
Reason for Not Administering Antithrombotic Therapy? STK
Denominator exclusion population ICD-9 CM diagnosis codes CSTK, CSTK-03
For Q1 2013 fVTE and Oral Factor Xa inhibitor in Stroke patients. STK-01
Last Known Well STK, STK-04
Does all medical record documentation need to be dated and timed? STK
Documentation of Stroke Education STK-08
TEDS for VTE Prophylaxis STK, STK-01
Is this considered a stroke clinical trial patient? STK
If tPA is given at an outside hospital by our Critical Transport Team, should we take credit? STK, STK-04
First Pass of a Mechanical Reperfusion Device / First Pass Time CSTK, CSTK-05
Thrombolytic therapy administered at satellite ED prior to hospital arrival STK
Why aren't there more newborn conditions listed for not exclusively feeding breast milk? PC-05
Graduated Compression Stockings as VTE Prophylaxis for Stroke Patients (STK-1) VTE-01, STK-1
How to abstact Last Known Well when there is too much information? STK
Clarification of CSTK-1 Measure Population Requirements CSTK-01
Failed Attempt at Thrombectomy CSTK-08, CSTK-11, CSTK-12
Does Appendix H, Table 2.2 exclude ambulatory stroke patients from the VTE prophylaxis? STK
Psychiatic Care Setting -Patient Inclusion HBIPS
Patient Population CSTK
Expired after discharge CSTK-02
What terms can be used for Comfort Measures Only? STK
Documentation for Stroke Education HF-1
ABstraction for Date Last Known Well STK
HBIPS-1 Timeframe for Screening Questions HBIPS
Time NIHSS performed CSTK-01
Stroke after admission-arrival to skin puncture CSTK -09 CSTK
thyroid CA PC-01
Sampling when both STK and CSTK are collected by a HCO CSTK
Unable to Calculate LDL Value Due to High Triglycerides STK-06
First NIHSS performed days after admission CSTK-01
Does a hold on anticoagulation count as a valid reason for not prescribing at discharge? STK-03
For patients transfused in Operating Room, how do we respond if there is no "written" order for transfusion. BM-05
can we accept a Drs documentation that it is not a hemorragic transformation CSTK, CSTK-05
Reason for not giving Nimodipine within 24 hours CSTK
Pre-anemia screening BM
In the Operating Room, is "Estimated Blood Loss" for PRBC'S considered transfusion criteria? BM-02
Version 4.4 - Time Last Known Well and Reason Extending IV Thrombolytic STK-04
NIHSS Score Clarification CSTK-01
How should we abstract thrombolytic administration in the 3 to 4.5 hr timeframe when a reason for not administering existed within 3 hrs? STK, STK-04
Rationale for Code Stroke Form as the Priority Data Source STK-4
Admitted for elective carotid intervention STK
Code 433.10 and Transient Ischemic Attack STK
HBIPS Discharge Status HBIPS
CSTK Procedure Times CSTK
STK-5 Antithrombotic - LOVENOX SQ STK
Time Last Known Well is after hospital arrival STK-04
Transfer in patients that are intubated CSTK-01
The latest update indicates a favorable mRS as 0 1 or 2 post stroke with pre mRS 3 4 or 5 CSTK
Why are there not more contraindications to vaginal deliveries? PC
ICH score documentation CSTK-03b
Appointment for Follow Up/ Release of Information HBIPS, HBIPS-7
Discharge Medications and Indication for Use HBIPS-6, HBIPS-7
Consideration of PRADAXA as anticoagulation therapy for patients with atrial fibrillation STK-03
AMA and Number of Antipsychotic Meds Prescribed at Discharge HBIPS-4, HBIPS-5
Why is ICD-9-CM Principal Diagnosis Code 436 used for ischemic stroke? STK
CSTK 4 Denominator Population CSTK-04
Functional Status at Discharge ACHF
Can post discharge documentation of a statin prescription be used in abstraction? STK-06
How is Length of Stay (LOS calculated for STK-1?) STK-01
Late Coded Stroke STK-4 and STK-5 STK, STK-4
Lovenox in reference to STK-2, STK-5, and STK-3 STK-2, STK-3, STK-5
What are the recommendations for VTE prophylaxis for stroke patients? STK-01
Significance of baseline mRS in calculation of CSTK-10 CSTK-10
Sampling Requirements for CSTK CSTK
Failed attempt at thrombectomy CSTK-08
History of low vertical incision documented BUT no documentation of classical incision. PC-01
What is the Date and Time Last Known Well? STK-04
What value should be selected when VTE prophylaxis is administered several days after admission? STK
When there is a discharge summary and an addendum present in the medical record, which should be used? STK
SCIP questions related to the April 2010 manual SCIP
Pre-transfusion platelet count allowable value BM-04b
CSTK4 documentation time? CSTK-04
Pneumonia diagnosis: ED/Direct Admint PN
Will certified Primary Stroke Centers be required to report the stroke performance measures as core measures? STK
If the patient enters the ED as a potential or actual TIA or hemorrhagic stroke patient, are the ED physicians required to document why the patient did not have IV thrombolytics initiated? STK
Why does a patient on another lipid-lowering medication qualify and fail statin prescribed at discharge? STK-06
MER code for combined billing for two hospitals-TSC CSTK, CSTK-08
DVT Prophylaxis and Ambulation STK, STK-01
Can an addendum be added to the medical record? STK-01
Please submit all Emergency Department measure questions directly to QnetQuest.org ED, ED-1, ED-2
Data Element Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Prescribed for LVSD at Discharge has an incomplete sentence ACHF-01
Can the following note be used as a Reason for Not Prescribing Anticoagulation Therapy? STK-03
Are the following examples acceptable Reasons for Not Prescribing Anticoagulation and Antithrombotic Therapy at Discahrge? STK, STK-02
Does the reason for not presciribing anticoagulation therapy have to be documented on the dau of discharge? STK-03
Graduated Compression Stocking (GCS) STK
Reason for Extending the Initiation of IV Thrombolytic STK, STK-04
Transmission of Continuing Care Plan (CCP) HBIPS, HBIPS-7
Will the new AHA recommendation of expasion of the time window for treatment wiht tPA be included in TJC measures/STK4? Other
Will Primary Stroke Certification continue? STK
Stroke Diagnosed Mid-Hospital Stay STK-5
Hunt and Hess & ICH Score Documentation CSTK-03
Will Evidence of Atherosclerosis remain a data element? STK-06
Proof that next level of care provider contact information was transmitted with the Transition of Care Record ACHF
Jan 2012 Follow-up monitoring VTE-05
What is the Admission Date? STK
Reason for Not Initiating IV Thrombolytic STK
STK-6 Reason for Not Prescribing a Statin Medication at Discharge STK
Documentation added to D/C summary after discharge STK-6
STK-6 "Evidence of Atherosclerosis" STK
Arrival Time for STK, CSTK and STK-OP Measures STK
Recommended ways to obtain mRS CSTK, CSTK-02
First Radiographic Image, CSTK 07 STK
Lovenox 40mg daily - Antithrombotic Therapy Administered by End of Hospital Day Two STK
COVID-19 CSTK
Number of cases needed for submission BM
Use of Sweet-Ease速 and PC-05 (Exclusive Breast Milk Feeding) PC-05
How should Last Known Well be abastracted when there is conflicting documentation in the medical record? STK-04
Stroke Module STK
Stroke that occurs after admission CSTK
Why are patients that receive t-PA in the ED and then transferred to another hospital excluded from STK-4? STK-04
What is the purpose of the Missing Branch ('X' Category Assignment for VTE Prophylaxis Date?) STK-01
Earliest Aneurysm Repair or Surgical Interv Procedure Time CSTK
Elective Carotid Intervention STK
Small vessel disease as Evidence of Atherosclerosis STK, STK-06
Arrival time for transferred patients CSTK-07
Can a patient undergoing Cardiac Surgery who received RBC's, FFP and Platelets be counted for more than one measure? BM
Is refusal of all IV's a Reason for Not Initiating IV Throbolytic Therapy? STK-04
OBS: remains in the ED or transfer to another unit not in the ED STK-OP
Optimal Medication Management ACHF
How to Answer Questions on Advanced Stroke Tab Intent to Perform MER CSTK-08
Comparative Data for Stroke Measures STK
VTE Prophlyaxis - Abstracting of Allowable Values STK-01
Will Evidence of Atherosclerosis remain a STK-6 data element? STK
PSC CSTK 01 population CSTK, CSTK-01
What should we do when conflicting or multiple times of last known well are documented? STK-04
Sampling Requirements for CSTK CSTK
Last Known Well STK-04
Why is a Reason for No VTE Prophylaxis needed with graduated compression stockings (GCS/TEDs?) STK, STK-01
Written discharge instructions for warfarin therapy VTE-05
Time Last Known Well STK
SCIP Inf-9 Urinary catheter removed on Postoperative Day 1 (POD 1 or Postoperative Day 2 (POD 2) with day of surgery being day zero ) SCIP, SCIP Inf-9
Clairfy time to recanalization CSTK, CSTK-07
Must the patient refuse both pharmacological and mechanical VTE prophylaxis to count as a reason for no prophylaxis? STK-01
Positive over negative findings STK-OP
Does CSTK - 03 include directly admitted transfers (that bypass ED?) CSTK-03
Initial Blood Pressure at Hospital Arrival Field Format CSTK-03
Should 'Yes' or 'No' be selected for IV Thrombolytic Initiation? STK
STK-10 Assessed for Rehabilitation Services STK-10
Multiple Procedure Times CSTK, CSTK-01
What is the Date and Time of Last Well Known? STK-04
Need information about the required import file specifications BM
SCIP- Neuraxial Anesthesia- Epidural for pain control placed post-op SCIP
Procedure Time Inclusion Terms CSTK-03
If a physician writes an order for SCDs, is this sufficient to select 'Yes' for VTE Prophylaxis? STK-01, VTE-01
Stroke Education Documentation Examples STK-08
Time Last Know Well -Stroke STK
STK-4 IV Thrombolytic Therapy STK
Are patients who have ischemic stroke occured after hospital arrival included in CSTK-01 population CSTK-01
Refusal of SCD's STK, STK-01
Triglyceride >400mg/dL STK
Is heparin 5000U SQ acceptable for antithrombitic administered by end day 2 STK
What constitutes a failed thrombectomy CSTK-11
Evidence of Atherosclerosis STK
Can we use E/M code 99211? ACHF
Is full medication reconciliation required by PSCs to meet the Medication Education measure component? STK-08
Statins at Discharge STK-06
Sampling Methodology for Stroke STK
mRS CSTK
Continuing Care Plan - Reason for Hospitalization HBIPS
Are retired Stroke Core Measures still required for comprehensive stroke centers? STK
doucumentation of ich and hunt hess CSTK-03
How should we abstract pharmacological VTE prophylaxis when the patient is NPO? STK
Data Abstraction for "Last Known Well" STK
Documentation for Rehabilitation Assessment STK-10
Inter-rater Reliability and Chart Re-asbstraction STK
Is admission day counted as day 1 for STK-1? STK
Mother's choice not to breast feed PC-05
Data Element- Violence Risk to Self HBIPS
Abstraction Tools ASR-OP-1
Statin prescibed the day after discharge STK-06, STK-08
what if Pradaxa (dabigatran is prescribed at discharge?) STK-02
Risk of Violence to Self HBIPS, HBIPS-1
Stroke Measures STK-7 and STK-9 STK
activity charting ACHF
Data abstraction for VTE Prophylaxis when administered prior to admission STK
Continuing Care Plan-Discharge Medications Indications for Use HBIPS
Can estimated blood loss (EBL be used for the data element pre-transfusion hemoglobin/hematocrit.) BM-02
Is it considered CMO if the palliative care consult was done and the patient refuses palliative care the next day? STK
Date Last Known Well STK
STK-1: IV Heparin for VTE Prophylaxis STK, STK-01
Statin therapy for patients 75yrs and older STK
Please submit all outpatient questions to QnetQuest.org OP
Reason for No VTE Prophylaxis - Hemorrhagic Stroke Patient STK-01
Stroke Measure Requirements STK
Earliest Reperfusion Procedure Date/Time for transferred patients CSTK-01
HBIPS Event Dates Prior to Admission HBIPS
Can an addendum be made to a pt's chart that has been d/c - Physician did not place the hunt & hess. CSTK
Antithrombotic Administration after t-PA STK-05
Who should perform mRS? CSTK-02
Multiple EMRs HBIPS
Initial Date/time of NIHSS teleneurologist CSTK, CSTK-01
Follow-up to UserQuestionId03Vte101043 VTE-05
What would I document as Last Known Well? STK, STK-4
Are patients admitted for elective basilar stenting excluded from the stroke chart audits? STK
When mutiple ejection fractions (EF are documented in the medical record, which value should we use?) ACHF
CSTK 3 CSTK, CSTK-03
Pradaxa (dabigatran prescribed at discharge) STK-02
One Episode of Care and Thrombolytic Therapy Administration STK
MER Attempted During this Encounter - Clot Dissolved CSTK-11
Follow-up to UserQuestionId03Stk100628 STK
CSTK 02, 05, and 06 Measures CSTK-01, CSTK-02, CSTK-05, CSTK-06
HBIPS- Restraint and Seclusion in ED HBIPS-3
When both SCDs and TEDS are applied on the same day , how are they abstracted? STK
Assessed for Rehabilitation STK
Earliest principal procedure time/first pass time CSTK
Transfer between the Psychiatric Unit and Acute Care Unit HBIPS
Reason for no VTE Prophylaxis - Elevated INR STK, STK-01
Next Level of Care Provider Same as Hospital Provider HBIPS
Footling breech code 652.81 as an exclusion for PC-02 PC-02a
NIHSS time STK
Referral to Next Level of Care HBIPS
Discharge Code and Transfers of Patients STK-OP
Discharged on Anticoagulation Therapy STK
Procedures Performed During Hospitalization ACHF
Documentation for tPA exclusion STK, STK-04
Is Xarelto an antithromotic for use in Stroke? Can it be used for antithrombotic med at discharge? STK, STK-02
Can I use VTE used during the Observation, given prior to hospital admission STK-1
Is there benchmark data available for HBIPS Data? HBIPS, HBIPS-1, HBIPS-1b, HBIPS-1c, HBIPS-1d, HBIPS-1e
Dabigatran (PRADAXA use in Stroke Patients) STK
Why aren't more exclusions to elective delivery considered? PC
Stroke VTE Prophylaxis STK-01
Stroke core measure data for PSC hospitals STK
Reason for Not Prescribing Anticoagulation Therapy at Discharge STK-03
Documentation ofJustification for Multiple Antipsychotic Medications HBIPS
Do we need to collect 90 day mRS on pts undergoing CEA/CAS? CSTK
EF on admission 15%. Day of discahrge EF 50-55% per ECHO. Do we answer Y for LVSD<40 . ACHF
Non Aneurysmal SAH Documentation CSTK-06
MER Eligibility CSTK
Date/Time of First Pass for CSTK-7 CSTK
Importance of exclusive breast milk feeding PC
NIHSS Timed After Discharge CSTK-01
Definition of validated and non-validated screening tool for substance use SUB-01
Nimodipine within 24 hours for non-aneurysmal SAH CSTK, CSTK-06
Reason for No VTE Prophylaxis STK, STK-01
PSC Certified Hospitals: Sampling Methodology to Use for CSTK 1 for 2019 STK
Reason for Not Initiating IV Thrombolytic-conflicting GWTG instructions STK-04
Elective carotid intervention documentation STK
STK-6 Data Entry in CMIP for Q1 2010 STK
Why does a patient treated with another lipid-lowering agent and with LDL < 100 fail the statin measure? STK-06
Reason for No Anticoagulation Therapy Prescribed at Discharge STK-03
Last Known Well Y/N? STK-4
Multiple TICI reperfusion grades CSTK-08
Which version of the specifications should be used for stroke data collection? STK
Why has this indicator has changed to include the word "elective"? STK
in 2016, will the vendors still be able to submit STK HCD for STK Certification for our hospitals? STK
Hunt & Hess/ ICH score documentation required by tele neuro radiology prior to transfer STK
ICD-9-CM Code 433.10 STK
Admission Date STK-01
Continuing Care Plan Document Questions HBIPS
Reason for Not Prescribing Antithrombotic / Anticoagulation at Discharge STK-02
Does the following documentation meet education regarding Risk factors for stroke? STK
Retirement of STK-7 Dysphagia Screen STK-07
Reason For Not Administering Antithrombotic By End of Hospital Day 2 STK
Appropriate Justification for Multiple Antipsychotic Meds at DC - Rationale for Allowable Value 4 HBIPS
Last Known Well Version 5.2 STK-4
Patient Referral to Next Level of Care Provider HBIPS
Follow-up to UserQuestion102705 CSTK
Time of the teleneurology NIHSS CSTK-01
Clarification of data elements needed CSTK-05b, CSTK-07
What version of the Joint Commision manuel will be used starting with January 1, 2010? STK-01, STK-02, STK-03, STK-04, STK-05, STK-06, STK-07, STK-08, STK-09, STK-10, VTE
Dietary Advice "consistent amount" of foods with Vitamin K rather than avoidance should be advised. VTE-05
Time Last Known Well - Conflicting Physician Documentation STK-04
Are MRI reports an acceptable data source for Evidence of Atherosclerosis? STK-06
How does new Prevnar recommendation affect Pneumovax administration? IMM
Documentation of Last Known well STK, STK-4
LDL Measured within first 48 hrs or 30 days prior to hospital arrival STK
Please submit all CMS mortality measure questions directly to QnetQuest.org MORT
Reason for not prescribing antithrombotic therapy at hospital discharge STK
Effect of NUBC's retirement of Point of Origin for Admission or Visit on Core Measures AMI-1, AMI-7, AMI-7a, AMI-8, AMI-8a, AMI-9, PN-3a, PN-5, PN-5c, PN-6a, PN-6b
CSTK-01 Procedures and Timing 1 calculation CSTK-01
NIHSS versus mNIHSS CSTK-05
Define who is considered a stroke team for STK 4. STK
Patient Receiving Continuing Care Plan Only HBIPS-6, HBIPS-7

Clinical Algorithm Questions

Data Quality Questions

Measure Verification Questions

Measure Verification Questions

Technical Questions

Performance Measurement System Vendor - General Questions

Statistical Questions

%DBQUERY{"TopicType =~ 'UserQuestion' AND Status =~ 'Database'"
 web="%BASEWEB%"
 sort="AnsweredDate"
 format="$expand(QuestionCategory)~$web.$topic~$encode($expand(Question))~$expand(RelatedMIFs)~$formatTime(info.date, '$day $mon $year')"
 separator="##"
}%


---++ Clinical Specification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div>
</noautolink>

---++ Clinical Algorithm Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Data Quality Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID01\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID04\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Technical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID02\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Performance Measurement System Vendor - General Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID00\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Statistical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID05\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>


Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback